Tianda Pharmaceuticals Limited (HKG:0455)
Hong Kong · Delayed Price · Currency is HKD 0.0970
0.00 (0.00%)
Mar 23, 2026, 3:49 PM HKT
Tianda Pharmaceuticals Revenue
In the year 2025, Tianda Pharmaceuticals had annual revenue of 322.95M HKD, down -2.12%. Tianda Pharmaceuticals had revenue of 186.31M in the half year ending December 31, 2025, a decrease of -18.50%.
Revenue
322.95M
Revenue Growth
-2.12%
P/S Ratio
0.65
Revenue / Employee
517.54K
Employees
624
Market Cap
208.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 322.95M | -6.99M | -2.12% |
| Dec 31, 2024 | 329.94M | -202.15M | -37.99% |
| Dec 31, 2023 | 532.09M | -14.61M | -2.67% |
| Dec 31, 2022 | 546.69M | 36.74M | 7.20% |
| Mar 31, 2022 | 509.96M | 35.62M | 7.51% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 1.93B |
| Lee's Pharmaceutical Holdings | 1.44B |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.08B |
| Kontafarma China Holdings | 914.71M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| PuraPharm Corporation | 336.11M |
| Pak Fah Yeow International | 214.31M |
| Extrawell Pharmaceutical Holdings | 52.65M |